R&D Universities and pharma companies need each other to create ... Academics and pharma executives seemingly live in very different worlds.
News UK team awarded grant for ‘second wave’ COVID-19 drug hunt A UK research group has been given £2.2 million in funding to seek out additional drugs to treat COVID-19, in case the first wave of therapies fail to show a benefit.
Partner Content Partner Content Review Microbiome Start-Up Success Stories & Business Models Your Invite - Microbiome Start-Up Focus Evening
News Norgine gets first EU approval for WHIM syndrome therapy Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
